BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23323458)

  • 21. External quality assessment of assays for hormones and tumor markers in Italian laboratories.
    Zucchelli GC; Pilo A; Malvano R; Signorini C; Bolelli GF; Albertini A
    Ann Ist Super Sanita; 1991; 27(3):479-86. PubMed ID: 1809068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inter- and intralaboratory quality-control survey of radioimmunoassay of insulin, thyroxin, thyrotropin, cortisol, digoxin, gastrin, beta 2-microglobulin, and IgE in Japan with commercially available kits.
    Shishiba Y; Irie M; Yamada H; Kinoshita F
    Clin Chem; 1983 Aug; 29(8):1501-7. PubMed ID: 6347430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of three quality control investigations on radioimmunological determination of thyrotropin using the "Munich model"].
    Marschner I; Wood WG; van Thiel D; Habermann J; König A; Scriba PC
    J Clin Chem Clin Biochem; 1983 May; 21(5):301-11. PubMed ID: 6875478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External quality assessment of serum hormone determinations in the Nordic countries.
    Ruokonen A; Leskinen E; Nyberg A; Vihko R
    Scand J Clin Lab Invest Suppl; 1984; 172():125-34. PubMed ID: 6599513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Report of Ad hoc Lp (a) standardization subcommittee in Standardization Committee of the Japan Society of Clinical Pathology. II. Results of the survey for the correction of-inter-laboratory variations by the unified reference material].
    Sakurabayashi I; Hosokaya S; Kameko M; Takahashi O; Kubono K; Ota N; Yamashita S; Igarashi T; Totsuka M; Fujita S; Manabe M; Shimizu K; Shigematsu T; Yamada S; Takahashi Y; Kaneko R; Kubo N; Katayama Y; Obe A; Noma A; Kawai T
    Rinsho Byori; 1996 Mar; 44(3):292-6. PubMed ID: 8857174
    [No Abstract]   [Full Text] [Related]  

  • 26. [The eleventh report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 14th survey in 1988). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1991 Mar; 28(3):323-8. PubMed ID: 2046189
    [No Abstract]   [Full Text] [Related]  

  • 27. Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan.
    Tanaka T; Takano K; Hanew K; Nishi Y; Igarashi Y; Hirano T; Saito T; Tachibana K; Yokoya S; Fujieda K; Shimatsu A; Hizuka N; Tsushima T; Irie M
    Endocr J; 1998 Aug; 45(4):459-65. PubMed ID: 9881894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The 5th Quality Control Survey for Radioisotopes in vitro Tests in Japan, 1983 (II)].
    Radioisotopes; 1984 Aug; 33(8):579-89. PubMed ID: 6505314
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of an in-house radioimmunoassay for human growth hormone.
    Wan Nazaimoon WM; Satgunasingam N; Khalid B
    Malays J Pathol; 1990 Jun; 12(1):13-20. PubMed ID: 2090885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An attempt for standardization of serum CA19-9 levels, in order to dissolve the gap between three different methods].
    Hayashi K; Hoshino T; Yanai M; Tsuchiya T; Kumasaka K; Kawano K
    Rinsho Byori; 2004 Jun; 52(6):500-5. PubMed ID: 15283162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants.
    Pilo A; Zucchelli GC; Chiesa MR; Masini S; Clerico A
    Ann Ist Super Sanita; 1991; 27(3):469-77. PubMed ID: 1809067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calibration and standardization in enzyme immunoassay].
    Kuwa K
    Nihon Rinsho; 1995 Sep; 53(9):2232-8. PubMed ID: 7474386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunoassay].
    Ichihara K
    Rinsho Byori; 1993 Jul; 41(7):737-42. PubMed ID: 8361042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in growth hormone immunoassays in clinical practice in Canada.
    Amed S; Delvin E; Hamilton J
    Horm Res; 2008; 69(5):290-4. PubMed ID: 18259108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity assessment of immunoassay kits for determination of urinary free cortisol concentrations.
    Horie H; Kidowaki T; Koyama Y; Endo T; Homma K; Kambegawa A; Aoki N
    Clin Chim Acta; 2007 Mar; 378(1-2):66-70. PubMed ID: 17174290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [II. Immunoassay as clinical test: quality control of radioimmunoassay].
    Ichihara K
    Rinsho Byori; 1983 Feb; Suppl 53():98-107. PubMed ID: 6345863
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control, quality assessment of laboratory tests, lipid profile.
    Kawano K
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():110-6. PubMed ID: 10926270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity.
    Gram J; Declerck PJ; Sidelmann J; Jespersen J; Kluft C
    Thromb Haemost; 1993 Nov; 70(5):852-7. PubMed ID: 8128445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The 6th quality control survey for radioisotope in vitro tests in Japan, 1984 (II)].
    Radioisotopes; 1985 Sep; 34(9):518-28. PubMed ID: 2418472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.